Literature DB >> 27510531

Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.

Stacey Dineen Rodenbeck1, Chad A Zarse2, Mikaela L McKenney-Drake1, Rebecca S Bruning1, Michael Sturek1, Neal X Chen2, Sharon M Moe2,3,4.   

Abstract

Background: Vascular smooth muscle cells (VSMCs) exhibit phenotypic plasticity, promoting vascular calcification and increasing cardiovascular risk. Changes in VSMC intracellular calcium ([Ca 2+ ] i ) are a major determinant of plasticity, but little is known about changes in [Ca 2+ ] i in chronic kidney disease (CKD). We have previously demonstrated such plasticity in aortas from our rat model of CKD and therefore sought to examine changes in [Ca 2+ ] i during CKD progression. Materials and
Methods: We examined freshly isolated VSMCs from aortas of normal rats, Cy/+ rats (CKD) with early and advanced CKD, and advanced CKD rats treated without and with 3% calcium gluconate (CKD + Ca 2+ ) to lower parathyroid hormone (PTH) levels. [Ca 2+ ] i was measured with fura-2.
Results: Cy/+ rats developed progressive CKD, as assessed by plasma levels of blood urea nitrogen, calcium, phosphorus, parathyroid hormone and fibroblast growth factor 23. VSMCs isolated from rats with CKD demonstrated biphasic alterations in resting [Ca 2+ ] i : VSMCs from rats with early CKD exhibited reduced resting [Ca 2+ ] i , while VSMCs from rats with advanced CKD exhibited elevated resting [Ca 2+ ] i . Caffeine-induced sarcoplasmic reticulum (SR) Ca 2+ store release was modestly increased in early CKD and was more drastically increased in advanced CKD. The advanced CKD elevation in SR Ca 2+ store release was associated with a significant increase in the activity of the sarco-endoplasmic reticulum Ca 2+ ATPase (SERCA); however, SERCA2a protein expression was decreased in advanced CKD. Following SR Ca 2+ store release, recovery of [Ca 2+ ] i in the presence of caffeine and extracellular Ca 2+ was attenuated in VSMCs from rats with advanced CKD. This impairment, together with reductions in expression of the Na + /Ca 2+ exchanger, suggest a reduction in Ca 2+ extrusion capability. Finally, store-operated Ca 2+ entry (SOCE) was assessed following SR Ca 2+ store depletion. Ca 2+ entry during recovery from caffeine-induced SR Ca 2+ store release was elevated in advanced CKD, suggesting a role for exacerbated SOCE with progressing CKD. Conclusions: With progressive CKD in the Cy/+ rat there is increased resting [Ca 2+ ] i in VSMCs due, in part, to increased SOCE and impaired calcium extrusion from the cell. Such changes may predispose VSMCs to phenotypic changes that are a prerequisite to calcification. Published by Oxford University Press on behalf of ERA-EDTA 2016. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  calcium signaling; cell phenotype; chronic kidney disease; rat model; vascular smooth muscle cells

Mesh:

Substances:

Year:  2017        PMID: 27510531      PMCID: PMC5837609          DOI: 10.1093/ndt/gfw274

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  85 in total

Review 1.  Chronic kidney disease-mineral-bone disorder: a new paradigm.

Authors:  Sharon M Moe; Tilman Drüeke; Norbert Lameire; Garabed Eknoyan
Journal:  Adv Chronic Kidney Dis       Date:  2007-01       Impact factor: 3.620

2.  Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats.

Authors:  Sabine Neudecker; Rebecca Walz; Kiran Menon; Elena Maier; Marie-Therese Bihoreau; Nicholas Obermüller; Bettina Kränzlin; Norbert Gretz; Sigrid C Hoffmann
Journal:  Am J Pathol       Date:  2010-12       Impact factor: 4.307

Review 3.  Vascular calcification in chronic renal failure: what have we learned from animal studies?

Authors:  Ellen Neven; Patrick C D'Haese
Journal:  Circ Res       Date:  2011-01-21       Impact factor: 17.367

4.  Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P)H-oxidase.

Authors:  Y Tada; S Yano; T Yamaguchi; K Okazaki; N Ogawa; M Morita; T Sugimoto
Journal:  Horm Metab Res       Date:  2012-12-07       Impact factor: 2.936

5.  FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Authors:  Chad D Touchberry; Troy M Green; Vladimir Tchikrizov; Jaimee E Mannix; Tiffany F Mao; Brandon W Carney; Magdy Girgis; Robert J Vincent; Lori A Wetmore; Buddhadeb Dawn; Lynda F Bonewald; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

6.  Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture.

Authors:  Roberto Berra-Romani; Amparo Mazzocco-Spezzia; Maria V Pulina; Vera A Golovina
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

7.  On the mechanism of impaired insulin secretion in chronic renal failure.

Authors:  G Z Fadda; S M Hajjar; A F Perna; X J Zhou; L G Lipson; S G Massry
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Authors:  Orlando M Gutiérrez; James L Januzzi; Tamara Isakova; Karen Laliberte; Kelsey Smith; Gina Collerone; Ammar Sarwar; Udo Hoffmann; Erin Coglianese; Robert Christenson; Thomas J Wang; Christopher deFilippi; Myles Wolf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

9.  The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease.

Authors:  Ingrid Lajdova; Viera Spustova; Adrian Oksa; Zuzana Kaderjakova; Dusan Chorvat; Marcela Morvova; Libusa Sikurova; Alzbeta Marcek Chorvatova
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

10.  ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.

Authors:  Sylvia Hoff; Jan Halbritter; Daniel Epting; Valeska Frank; Thanh-Minh T Nguyen; Jeroen van Reeuwijk; Christopher Boehlke; Christoph Schell; Takayuki Yasunaga; Martin Helmstädter; Miriam Mergen; Emilie Filhol; Karsten Boldt; Nicola Horn; Marius Ueffing; Edgar A Otto; Tobias Eisenberger; Mariet W Elting; Joanna A E van Wijk; Detlef Bockenhauer; Neil J Sebire; Søren Rittig; Mogens Vyberg; Troels Ring; Martin Pohl; Lars Pape; Thomas J Neuhaus; Neveen A Soliman Elshakhs; Sarah J Koon; Peter C Harris; Florian Grahammer; Tobias B Huber; E Wolfgang Kuehn; Albrecht Kramer-Zucker; Hanno J Bolz; Ronald Roepman; Sophie Saunier; Gerd Walz; Friedhelm Hildebrandt; Carsten Bergmann; Soeren S Lienkamp
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

View more
  11 in total

1.  Effect of metabolic syndrome and aging on Ca2+ dysfunction in coronary smooth muscle and coronary artery disease severity in Ossabaw miniature swine.

Authors:  Jill K Badin; Rebecca S Bruning; Michael Sturek
Journal:  Exp Gerontol       Date:  2018-05-03       Impact factor: 4.032

2.  Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways.

Authors:  Neal X Chen; Kalisha D O'Neill; Sharon M Moe
Journal:  Kidney Int       Date:  2017-10-09       Impact factor: 10.612

Review 3.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

4.  Phosphate-induced ORAI1 expression and store-operated Ca2+ entry in aortic smooth muscle cells.

Authors:  Ke Ma; Ping Liu; Tamer Al-Maghout; Basma Sukkar; Hang Cao; Jakob Voelkl; Ioana Alesutan; Burkert Pieske; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2019-08-05       Impact factor: 4.599

5.  Dietary potassium regulates vascular calcification and arterial stiffness.

Authors:  Yong Sun; Chang Hyun Byon; Youfeng Yang; Wayne E Bradley; Louis J Dell'Italia; Paul W Sanders; Anupam Agarwal; Hui Wu; Yabing Chen
Journal:  JCI Insight       Date:  2017-10-05

Review 6.  Calcium in Vascular Smooth Muscle Cell Elasticity and Adhesion: Novel Insights Into the Mechanism of Action.

Authors:  Yi Zhu; Jing Qu; Li He; Feng Zhang; Zijing Zhou; Shanzhong Yang; Yong Zhou
Journal:  Front Physiol       Date:  2019-08-07       Impact factor: 4.566

7.  Non-Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors:  John G Damrath; Neal X Chen; Corinne E Metzger; Shruthi Srinivasan; Kalisha O'Neill; Annabel Biruete; Keith G Avin; Joseph M Wallace; Matthew R Allen; Sharon M Moe
Journal:  JBMR Plus       Date:  2022-02-11

8.  Intracellular Ca2+ Dysregulation in Coronary Smooth Muscle Is Similar in Coronary Disease of Humans and Ossabaw Miniature Swine.

Authors:  Jill K Badin; Caleb Eggenberger; Stacey Dineen Rodenbeck; Zubair A Hashmi; I-Wen Wang; Jose P Garcia; Mouhamad Alloosh; Michael Sturek
Journal:  J Cardiovasc Transl Res       Date:  2021-07-20       Impact factor: 4.132

9.  Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats.

Authors:  Yu-Chen Shi; Wei-Wei Lu; Yue-Long Hou; Kun Fu; Feng Gan; Shu-Juan Cheng; Shao-Ping Wang; Yong-Fen Qi; Jing-Hua Liu
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

Review 10.  Skeletal and cardiovascular consequences of a positive calcium balance during hemodialysis.

Authors:  Rosilene M Elias; Sharon Moe; Rosa M A Moysés
Journal:  J Bras Nefrol       Date:  2021 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.